Davos Alzheimers Collaborative Inc is located in Washington, DC. According to its NTEE Classification (G83) the organization is classified as: Alzheimers Disease, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Davos Alzheimers Collaborative Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
SEE PART III LINE 1.
Describe the Organization's Program Activity:
Part 3 - Line 4a
GLOBAL COHORTS - DAC IS BUILDING GLOBAL COHORTS TO ADVANCE UNDERSTANDING OF ALZHEIMER'S AMONG DIVERSE POPULATIONS. THIS DATA WILL PROVIDE THE FOUNDATION FOR IDENTIFYING NEW BIOMARKERS AND DEVELOPING TARGETED TREATMENTS THAT WORK FOR PEOPLE WORLDWIDE. IN 2021, DAC COMPLETED A CROSS-REGION HETEROGENEITY EXPLORATION PILOT (PRS) TO ENGAGE COHORTS. THIS INCLUDED THE MIDDLE EAST, SOUTH EAST ASIA, AFRICA AND SOUTH AMERICA AND CONNECT WITH MORE ADVANCED COHORTS IN THE WESTERN WORLD TO TEST OUR ABILITIES TO COMBINE AND FEDERATE DATA AND PROVIDE A ROADMAP FOR FURTHER INTEGRATION OF RACIALLY DISTINCT AND DIVERSE COHORTS. DAC RECRUITED 14 COHORTS AROUND THE GLOBE. OUTREACH TO COHORTS WERE TARGETED THAT HAVE THE STRONGEST ALIGNMENT WITH THE SCIENTIFIC PLAN AND ACCESS TO THE TARGETED MEASUREMENTS.
HEALTHCARE SYSTEM PREPAREDNESS - DAC IS INVESTING TO TRANSFORM THE WAY HEALTHCARE SYSTEMS WORLDWIDE DETECT, DIAGNOSE AND TREAT ALZHEIMER'S. THE GOAL IS TO TAKE ADVANTAGE OF FUTURE INNOVATIONS TO IMPROVE THE QUALITY OF LIFE FOR PEOPLE EVERYWHERE. IN 2021, DAC INITIATED 7 FLAGSHIP PROJECTS IN 6 COUNTRIES. THE INITIAL CENTRALLY-DRIVEN PROJECT FOCUSED ON EARLY DETECTION. DAC ISSUED RFP FOR LOCALLY-DRIVEN PROJECT PROPOSALS THAT FOCUSED ON EARLY DETECTION. OVER 70 RESPONSES FROM 21 COUNTRIES WERE RECEIVED IN 2021.
GLOBAL CLINICAL TRIALS - DAC IS BUILDING A GLOBAL NETWORK OF CLINICAL TRIAL SITES AND A SUPPORTING TECHNOLOGY PLATFORM TO REDUCE THE COST AND TIME OF BRINGING NEW TREATMENTS TO MARKET. DAC DEVELOPED A NETWORK OF MORE THAN 15 EUROPEAN SITES ORGANIZED FOR ACCELERATING STUDIES AND IMPLEMENTING NOVEL TRIAL DESIGNS. DAC VALUATED SITES GLOBALLY AND IDENTIFIED OPPORTUNITIES IN AFRICA, SOUTH KOREA, SINGAPORE, AUSTRALIA, JAPAN AND CHINA.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
George Vradenburg Chair & President | OfficerTrustee | 20 | $0 |
Andrew Holzapfel COO | OfficerTrustee | 30 | $0 |
Freda Lewis Hall Treasurer | OfficerTrustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Weber Shandwick Media Relations | 12/30/21 | $218,787 |
Global Genomic Medicine Collaborative Cohort Data Analysis | 12/30/21 | $555,141 |
Global Alzheimer's Platform Foundation Clinical Trial Innovation | 12/30/21 | $199,518 |
Ad Astra Associates Llc Develop A Resource Mobilization Plan | 12/30/21 | $172,982 |
High Lantern Group Admin, Marketing, Pr, And It | 12/30/21 | $608,934 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $14,514,120 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $14,514,120 |
Total Program Service Revenue | $0 |
Investment income | $0 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $14,514,120 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $343,000 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $608,934 |
Fees for services: Legal | $196,900 |
Fees for services: Accounting | $36,314 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $1,336,465 |
Advertising and promotion | $232,788 |
Office expenses | $2,918 |
Information technology | $135 |
Royalties | $0 |
Occupancy | $0 |
Travel | $4,920 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $3,125 |
All other expenses | $0 |
Total functional expenses | $2,767,999 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $12,435,461 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $7,590 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $12,443,051 |
Accounts payable and accrued expenses | $696,930 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $696,930 |
Net assets without donor restrictions | $11,146,121 |
Net assets with donor restrictions | $600,000 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $12,443,051 |
Over the last fiscal year, Davos Alzheimers Collaborative Inc has awarded $338,000 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
Boston, MA PURPOSE: SUPPORT BOSTON UNIVERSITY AND THE PURPOSE OF THE DAVOS ALHEIMER'S COLLABORATIVE FUND. RESTRICTED FUND FOR SUPPORT OF THE WORK OF DR. RHODA AU ALZEHEIMER'S DISEASE RESEARCH. | $313,000 |
Washington, DC PURPOSE: LAUSANNE VIII WORKSHOP SPONSORSHIP | $25,000 |
Over the last fiscal year, we have identified 2 grants that Davos Alzheimers Collaborative Inc has recieved totaling $2,464,108.
Awarding Organization | Amount |
---|---|
Usagainstalzheimers Washington, DC PURPOSE: DURING 2021, THE DAVOS ALZHEIMER'S COLLABORATIVE PROGRAM BEGAN OPERATING AS A STAND-ALONE ENTITY. USA2 REMOVED DAC FROM ITS BOOKS BY TRANSFERRING DAC'S NET ASSET BALANCE DURING THE YEAR ENDED DECEMBER 31, 2021, WHICH TOTALED $2,251,108. | $2,251,108 |
Tmcity Foundation Centerville, DE PURPOSE: TO PROMOTE ITS CHARITABLE PURPOSE | $213,000 |
Organization Name | Assets | Revenue |
---|---|---|
National Federation Of The Blind Inc Baltimore, MD | $35,001,742 | $21,045,026 |
Equal Access International Washington, DC | $4,995,073 | $20,152,774 |
Epilepsy Foundation Of America Bowie, MD | $20,384,765 | $21,897,167 |
Dont Ever Give Up Inc Cary, NC | $15,801,113 | $21,347,428 |
Action Wellness Philadelphia, PA | $6,892,725 | $16,798,193 |
Blossom Philadelphia Philadelphia, PA | $11,542,334 | $13,231,911 |
United Disabilities Services Lancaster, PA | $32,057,635 | $19,427,155 |
Lupus Foundation Of America Inc Washington, DC | $8,838,757 | $15,023,543 |
Gha Autism Supports Albemarle, NC | $14,413,314 | $16,912,491 |
The American Board Of Anesthesiology Inc Raleigh, NC | $83,891,819 | $14,791,696 |
Maryland University Of Integrative Health Inc Laurel, MD | $11,498,373 | $12,162,798 |
American Society Of Cataract & Refractive Surgery Fairfax, VA | $11,891,572 | $16,090,211 |